Publications by authors named "Milothy Parthipan"
Article Synopsis
- Older adults with metastatic prostate cancer face significant treatment-related symptoms, and frailty may increase the severity of these symptoms.
- A study was conducted with 90 participants who reported their symptoms during one treatment cycle, revealing that fatigue, insomnia, and poor wellbeing were the most common issues experienced.
- The findings indicated that frail participants had higher incidences of poor wellbeing, and while symptom improvement was limited, weekly improvements in fatigue, appetite, and insomnia were noted in those receiving chemotherapy.
Article Synopsis
- The study investigates the relationship between physical activity and cancer treatment symptoms in older adults, specifically those over 65 with metastatic prostate cancer starting various treatments.
- It evaluates the feasibility of daily step count monitoring using smartphones and correlates step counts with treatment-emergent symptoms, finding that many participants experienced significant declines in physical activity along with moderate to severe symptoms.
- Results indicate that daily monitoring was well-received by participants, showing high retention and engagement, and a notable predictive relationship between decreased physical activity and increased severity of symptoms.
Introduction: Exploring symptom experiences of older men during metastatic prostate cancer treatment can help clinicians identify unmet supportive care needs that, if addressed, could improve toxicity management and enhance patient wellbeing. Previous qualitative studies of older adults with advanced prostate cancer have focused on the psychological experience rather than the overall symptom experience. Therefore, the objective of this study was to understand the lived experience of symptoms and supportive care needs in older men undergoing treatment for metastatic prostate cancer.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted to evaluate the feasibility of remote symptom monitoring (RSM) for older adults (65+) undergoing treatments for metastatic prostate cancer (mPC), aiming to improve their health outcomes during chemotherapy and other therapies.
- Participants completed daily and weekly questionnaires about their symptoms, which triggered alerts to oncologists for any severe symptoms reported.
- The results showed high engagement with RSM, with 93% response rates, 93% participant satisfaction, and significant reporting of severe symptoms among the elderly, despite some finding it burdensome.